Zobrazeno 1 - 10
of 175
pro vyhledávání: '"Villaverde-Hueso A"'
Autor:
Laura Llamosas-Falcón, Germán Sánchez-Díaz, Elisa Gallego, Ana Villaverde-Hueso, Greta Arias-Merino, Manuel Posada de la Paz, Verónica Alonso-Ferreira
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-8 (2022)
Abstract Muscular dystrophies (MD) are a group of rare hereditary degenerative diseases. Our aim was to analyze the mortality pattern in Spain from 1981 to 2016 to assess the temporal trend and discern possible geographic differences using population
Externí odkaz:
https://doaj.org/article/4a3dab243d764ebf8ad59aa47cb26a2a
Autor:
Ortega-Torres, Angelica, Sánchez-Díaz, Germán, Villaverde-Hueso, Ana, Posada de la Paz, Manuel, Alonso-Ferreira, Verónica
Publikováno v:
In Gaceta Sanitaria January-February 2020 34(1):37-43
Autor:
Angelica Ortega-Torres, Germán Sánchez-Díaz, Ana Villaverde-Hueso, Manuel Posada de la Paz, Verónica Alonso-Ferreira
Publikováno v:
Gaceta Sanitaria, Vol 34, Iss 1, Pp 37-43 (2020)
Resumen: Objetivo: Conocer la mortalidad directamente atribuida a la telangiectasia hemorrágica hereditaria (THH) en España, su tendencia temporal y la posible variabilidad geográfica. Método: El total de los fallecidos por THH de base poblaciona
Externí odkaz:
https://doaj.org/article/296b9d2d375a4787a4ed0bc338371cf3
Autor:
Laura Llamosas-Falcón, Eva Bermejo-Sánchez, Germán Sánchez-Díaz, Ana Villaverde-Hueso, Manuel Posada de la Paz, Verónica Alonso-Ferreira
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 14, Iss 1, Pp 1-8 (2019)
Abstract Background Tetralogy of Fallot (TOF) is the most frequent cyanotic congenital heart defect. TOF mortality has fallen remarkably in recent years due to therapeutic advances. Accordingly, the aim of this study was to assess temporal and spatia
Externí odkaz:
https://doaj.org/article/2cf1cb93cfe2478ca6cf15fa64b3737f
Autor:
Coi, Alessio, Santoro, Michele, Villaverde-Hueso, Ana, Di Paola, Michele Lipucci, Gainotti, Sabina, Taruscio, Domenica, de la Paz, Manuel Posada, Bianchi, Fabrizio
Publikováno v:
Public Health Genomics, 2016 Jan 01. 19(2), 108-115.
Externí odkaz:
https://www.jstor.org/stable/26778247
Autor:
Elisa Gallego, Greta Arias-Merino, Germán Sánchez-Díaz, Ana Villaverde-Hueso, Manuel Posada de la Paz, Verónica Alonso-Ferreira
Publikováno v:
International Journal of Environmental Research and Public Health
Volume 20
Issue 5
Pages: 4374
Volume 20
Issue 5
Pages: 4374
Familial Mediterranean Fever (FMF) is a rare, hereditary, auto-inflammatory disease. The aims of this study were to explore the time trend and geographical distribution of hospitalizations in Spain from 2008 to 2015. We identified hospitalizations of
Autor:
Diego Fernández-Lázaro, Juan Luis García Hernández, Alberto Caballero García, Aurora Caballero del Castillo, María Villaverde Hueso, Juan Jesús Cruz-Hernández
Publikováno v:
Diagnostics, Vol 10, Iss 7, p 443 (2020)
The term liquid biopsy (LB) refers to the study of circulating tumor cells, circulating tumors nucleic acids free of cells or contained in exosomes, and information about platelets associated with tumors. LB can be performed in different biofluids an
Externí odkaz:
https://doaj.org/article/5304065890184e99a155a65e8d234c6b
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Hens, Manuel, Villaverde-Hueso, Ana, Alonso, Veronica, Abaitua, Ignacio, de la Paz, Manuel Posada
Publikováno v:
The European Journal of Health Economics, 2014 May 01. 15(4), 433-437.
Externí odkaz:
https://www.jstor.org/stable/24033374
Autor:
Macarena Garrido-Estepa, Greta Arias-Merino, Verónica Alonso-Ferreira, Ana Villaverde-Hueso, Manuel Posada de la Paz
Publikováno v:
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation. 31(10)
Toxic oil syndrome (TOS) is a multisystemic disease due to a massive intoxication. To evaluate physical and mental health of TOS patients, we used the Health Assessment Questionnaire (HAQ) and the Patient Health Questionnaire-9 (PHQ-9). Additionally,